Why the study?
Determining whether malignant hyperthermia susceptibility can be principally genetically determined is of high importance to prevent its lethality through better understanding of pathogenesis.
Design
Brief report and review
Authors
Loading...
Genetic testing for MHS remains adjunctive to CHCT; leaves open whether it can become the principal diagnostic method.
This review provides updates on the genetics of malignant hyperthermia susceptibility to better understand the condition and current research.
Beebe et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: